Navigation Links
Genomma Lab Internacional Acquires Brands Flor de Naranja Sanborns(MR), Teatrical and Henna Egipcia From Grupo Sanborns
Date:6/5/2009

- These acquisitions reinforce Genomma Lab's presence in the cosmetics and hair product categories and mark the Company's entrance into the lotions and perfumes segments

- Genomma Lab continues the acquisition program announced during the Company's public offering, which took place in June 2008

MEXICO CITY, June 5 /PRNewswire-FirstCall/ -- Genomma Lab Internacional S.A.B. DE C.V. (BMV: LAB) ("Genomma Lab" or "the Company"), one of the largest and most diversified Mexican companies in the pharmaceutical and personal care products categories, announced the acquisition of the brand of lotions Flor de Naranja Sanborns(MR), the brand properties for Teatrical creams, Henna Egipcia hair color, and a 99 year license for the use of Sanborns(MR) brands from the acquired brands.

With this acquisition, Genomma Lab strengthens its presence in the face cream and body lotions markets as well as hair products categories, while expanding its offering of lotion and perfume products. Sales for the acquired brands reached Ps. 110.3 million during the trailing twelve months ended April 30, 2009.

Teatrical is a traditional and popular brand in Mexico. Registered for sale since 1928, its range of face creams and body lotions has been on the minds of several generations of consumers for over 80 years.

Cologne water Flor de Naranja Sanborns(MR) has an 82-year trajectory and is also one of the most recognized brands in its market segment.

Finally, Henna Egipcia is a recognized brand of discreet hair color products with a nearly 45-year history in the marketplace.

"These acquisitions are in line with the Company's growth strategy implemented since the public offering, which includes the generation and acquisition of new brands and products in order to increase its presence in the medicinal and personal care products markets," stated Mr. Rodrigo Herrera, Chief Executive Officer.

Genomma Lab seeks to revitalize its acquired brands and strengthen its expansion via the application of its business model.

Genomma Lab paid for this transaction with its own resources at a multiple of 2.7x sales for the trailing twelve months for a total of Ps. 300 million, of which approximately 50% will be paid in 10 payments over 10 years.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico with international presence. Genomma develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share.

The Company is listed on the Mexican Stock Exchange under the ticker symbol "LAB.B" (Bloomberg: labb.mx).

Web Site: www.genommalab.com


'/>"/>
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genomma Lab Internacional Announces First Quarter 2009 Results
2. Genomma Lab Acquires the Mexican Company Medicinas y Medicamentos Nacionales
3. Genomma Lab Internacional Announces Fourth Quarter and Full Year 2008 Results
4. Webcast Alert: Genomma Lab Announces Fourth Quarter 2008 Earnings Webcast
5. Genomma Lab Announces Updated Fourth Quarter 2008 Guidance
6. Genomma Lab, New Participant in Market-Maker Program
7. Genomma Lab Announces Initiation of Stock Repurchase Fund
8. Genomma Lab Announces the Successful Launch of the Ma Evans Brand
9. Genomma Lab Announces 2009 Earnings Guidance
10. Genomma Lab Internacional Acquires UNIGASTROZOL
11. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. announces Second Quarter 2008 Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... For many artists, the act of blending paint ... it into a science. , Using the new, highly precise METTLER TOLEDO ML204T ... add depth and meaning to his works. What’s more, it has allowed him to ...
(Date:5/2/2016)... ... May 02, 2016 , ... The debilitating disease of arthritis can bring patients ... most patients must deal with prescription costs to treat arthritis over the course of ... savings at the pharmacy on many common prescriptions. , Arthritis , Although arthritis is ...
(Date:5/2/2016)... ... May 02, 2016 , ... Summit BHC (Summit), a ... of Twin Lakes Recovery Center. Located east of Atlanta in Monroe, Georgia, ... The residential facility is set on 34 acres of beautiful, secluded property that ...
(Date:5/2/2016)... ... May 02, 2016 , ... Marshall Votta, Josh Holmes and Laura ... development roles to drive RowdMap Inc.’s market growth across both health plans and provider ... order to succeed in value based care. , Marshall Votta joins RowdMap, Inc. as ...
(Date:5/1/2016)... , ... May 02, 2016 , ... ... for original 1968 Jimi Hendrix Merriweather Post Pavilion in Columbia, Maryland concert posters. ... concert poster. The concert was held on August 16. According to Hawley, “The ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
(Date:4/28/2016)... YORK , April 28, 2016 ... online consumer insights on healthcare, announced today that it ... their report Cool Vendor in Life Sciences, 2016, ... April 15, 2016.  The report focuses on life-science- oriented ... gain insight from patients and doctors, confirm medication ingestion, ...
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... of oral drug delivery systems, announced today that the Company ... Joseph Gunnar & Co. LLC, taking place on ... Nadav Kidron , CEO of Oramed, will present a ...   PIONEERS 2016, presented by Joseph Gunnar ...
Breaking Medicine Technology: